Tulobuterol
From Wikipedia, the free encyclopedia
|
Tulobuterol
|
|
| Systematic (IUPAC) name | |
| 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol | |
| Identifiers | |
| CAS number | |
| ATC code | R03 |
| PubChem | |
| Chemical data | |
| Formula | C12H18ClNO |
| Mol. mass | 227.730 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Inhaled, oral |
Tulobuterol (INN) is a beta2-adrenergic receptor agonist.
|
||||||||||||||||||||||||||

